Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Deborah Huveldt"'
Autor:
Antonis Kourtidis, Masahiro Yanagisawa, Deborah Huveldt, John A Copland, Panos Z Anastasiadis
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129964 (2015)
Altered protein expression and phosphorylation are common events during malignant transformation. These perturbations have been widely explored in the context of E-cadherin cell-cell adhesion complexes, which are central in the maintenance of the nor
Externí odkaz:
https://doaj.org/article/016667c5939b430f9c4e9fc59447c720
Autor:
Deborah Huveldt, Laura J Lewis-Tuffin, Brett L Carlson, Mark A Schroeder, Fausto Rodriguez, Caterina Giannini, Evanthia Galanis, Jann N Sarkaria, Panos Z Anastasiadis
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56505 (2013)
Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence patter
Externí odkaz:
https://doaj.org/article/8019741ab28644f0b91fe851b0421d34
Autor:
Christine M. Lohse, Masahiro Yanagisawa, John A. Copland, John C. Cheville, Pamela A. Kreinest, Panos Z. Anastasiadis, Deborah Huveldt, Alexander S. Parker
Publikováno v:
Journal of Biological Chemistry. 283:18344-18354
p120 catenin is a cadherin-associated protein that regulates Rho GTPases and promotes the invasiveness of E-cadherin-deficient cancer cells. Multiple p120 isoforms are expressed in cells via alternative splicing, and all of them are essential for HGF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7cdb635ca26d3f68fbaea4ac48c2e43
https://doi.org/10.1074/jbc.m801192200
https://doi.org/10.1074/jbc.m801192200
Autor:
Caterina Giannini, Evanthia Galanis, Mark A. Schroeder, Laura J. Lewis-Tuffin, Brett L. Carlson, Deborah Huveldt, Jann N. Sarkaria, Fausto J. Rodriguez, Panos Z. Anastasiadis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 2, p e56505 (2013)
PLoS ONE, Vol 8, Iss 2, p e56505 (2013)
Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence patter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f85657375af559750abe511450b887
http://europepmc.org/articles/PMC3572988
http://europepmc.org/articles/PMC3572988
Autor:
Karen L Moodie, Jay M. Baraban, Laura J. Lewis-Tuffin, Deborah Huveldt, Miaoliang Liu, Sudesh Agrawal, Antonis Kourtidis, Chuanshen Wu, Siu P. Ngok, Arie Horowitz, Peter Storz, Himabindu Reddy Seerapu, Ruth Marx, Panos Z. Anastasiadis, Rory Geyer
Publikováno v:
The Journal of Cell Biology
VEGF causes translocation of Syx from endothelial cell junctions, promoting junction disassembly, whereas Angtiopoietin-1 maintains Syx at the junctions and stabilizes them.
Vascular endothelial growth factor (VEGF) and Ang1 (Angiopoietin-1) hav
Vascular endothelial growth factor (VEGF) and Ang1 (Angiopoietin-1) hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65402e51baa2d64a92cf65afde19e7d0
https://pubmed.ncbi.nlm.nih.gov/23253477
https://pubmed.ncbi.nlm.nih.gov/23253477
Autor:
John A. Copland, Deborah Huveldt, Antonis Kourtidis, Panos Z. Anastasiadis, Masahiro Yanagisawa
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0129964 (2015)
PLoS ONE, Vol 10, Iss 6, p e0129964 (2015)
Altered protein expression and phosphorylation are common events during malignant transformation. These perturbations have been widely explored in the context of E-cadherin cell-cell adhesion complexes, which are central in the maintenance of the nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3d33b81f18b146edcc39eba3fec8a7
https://doi.org/10.1371/journal.pone.0129964
https://doi.org/10.1371/journal.pone.0129964